Skip to content

Cabot

US · CBT #2289 by market cap Listed 1970
75.41 -1.70 -2.20%
Live - 5344 symbols - heartbeat 297s ago · 2026-10-08 07:00
Pre-market 75.00 -0.54%
After-hours 75.41 0.00%
Market cap
3.89B
P/B
2.43
EPS
6.02
Reader sentiment Are you bullish or bearish on CBT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
16.17 fair value ≈ 90.64 165.12
  • Implied fair-value range of 16.17-165.12, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -16.8% below the average-multiple fair value of 90.64.

Valuation each multiple against its own 5-year range

P/B ratio 2.48 Cheap vs history 9th percentile
5-year average 3.54 · #35 of 56 in Specialty Chemicals
P/E ratio 21.60 Expensive vs history 80th percentile
5-year average 15.06 · forward 11.76 · #12 of 32 in Specialty Chemicals
P/S ratio 1.10 In line with history 61st percentile
5-year average 1.09 · forward 1.08 · #22 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Cabot (CBT) 3.89B 21.12 2.43 2.42%
Linde (LIN) 223.11B 31.22 5.71 1.28%
Ecolab (ECL) 77.96B 37.33 7.75 1.02%
Sherwin-Williams (SHW) 76.47B 29.06 19.84 1.01%
Air Products & Chemicals (APD) 61.93B -1,324.38 4.46 2.59%
PPG Industries (PPG) 23.36B 15.03 2.77 2.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value94.98 Economic moatNone UncertaintyMedium

Trading 26.0% below Morningstar's fair value estimate.

Fair value

Cabot Corp earns a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 19% discount to our quantitative fair value estimate of $94.98 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The firm's valuation metrics strengthen our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's enterprise value to market value ratio of 1.3 lies in the top 40% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. We believe this is a sign that shares could be undervalued.

The firm's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 8.5%, a core component of profitability, falls in the top 30% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which further promotes our favorable price/fair value ratio.

Economic moat

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:00:03 · For reference only, not investment advice and not tailored to your situation.